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Abstract  
 
 A review of currently available data on in vivo induced chromosome damage in the 
blood lymphocytes of astronauts proves that, after protracted exposure of a few months or 
more to space radiation, cytogenetic biodosimetry analyses of blood collected within a 
week or two of return from space provides a reliable estimate of equivalent radiation dose 
and risk. Recent studies indicate that biodosimetry estimates from single spaceflights lie 
within the range expected from physical dosimetry and biophysical models, but very large 
uncertainties are associated with single individual measurements and the total sample 
population remains low. Retrospective doses may be more difficult to estimate because of 
the fairly rapid time-dependent loss of “stable” aberrations in blood lymphocytes. Also, 
biodosimetry estimates from individuals who participate in multiple missions, or very 
long (interplanetary) missions, may be complicated by an adaptive response to space 
radiation and/or changes in lymphocyte survival and repopulation. A discussion of 
published data is presented and specific issues related to space radiation biodosimetry 
protocols are discussed. 
1. Introduction 
Human spaceflight missions have increased in duration over the years. From brief 
forays lasting up to a few days, missions have extended to months on board the 
International Space Station (ISS), and future Mars exploration missions could extend as 
long as three years. This increased time in space has raised concerns about the potential 
health effects of radiation exposures incurred during missions. Since cancer is the main 
health concern related to space radiation exposure, limits are based on the lifetime excess 
cancer risk (Cucinotta and Durante 2006) and are currently restricted to an excess lifetime 
cancer mortality risk of no more than 3% (NCRP 2000). 
The space radiation environment is a complex mixture of different types of radiation 
and is very different from the terrestrial radiation environment. The primary sources of 
radiation in outer space are galactic cosmic rays (GCR), protons and electrons trapped in 
the Earth’s magnetic field, and infrequent solar particle events (SPE). In addition, 
secondary radiation, such as neutrons and light charged particles, is created by 
interactions of high-charge (Z) and high-energy (E) nuclei (HZE particles) with 
spacecraft shielding material and with the human body itself (NCRP 2000). Although 
HZE particles contribute only a few percent to the particle flux in space, the significantly 
higher ionizing energy and greater penetration power of this type of radiation could 
contribute significantly to biological effects.   
Health risks to crew members are currently assessed from physical measurements of 
radiation dose measured using passive thermoluminescent dosimeters (TLDs) and plastic 
nuclear track detectors (PNTDs). These measurements provide accumulated absorbed 
skin doses that are combined with computerized anatomical models and radiation 
transport codes that estimate the effects of shielding. The data are used to calculate 
radiation doses to specific organs and to assess the corresponding health risk. However, in 
this process substantial limitations arise that lead to significant uncertainty in estimating 
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the biologically important dose (Cucinotta and Durante 2006). Quality factors for space 
radiation risk coefficients (mostly derived from the A-bomb survivors database), and the 
dose and dose-rate effectiveness factor, are all quantities affected by large uncertainty. In 
addition, the location of crew dosimeters can not always be assured, individual radio-
sensitivity is totally neglected in the risk models, and synergism between microgravity 
and radiation is still poorly understood. Recently, biodosimetry programs have been 
introduced that derive equivalent dose or risk from direct measurements of cytogenetic 
damage in the peripheral blood lymphocytes of crew members (George et al 2001a). 
These data have the added advantage of taking into account individual radio-sensitivity in 
addition to the influence of microgravity effects and other stress conditions, and can be 
very useful to benchmark the current models that are used to estimate risk from physical 
dosimetry measurements (NCRP 2002).   
Cytogenetic biodosimetry methods have been used extensively for assessing radiation 
exposures, and remain the most sensitive in vivo indicator of dose available to date (IAEA 
2001). Dicentric chromosomes have been used for many years to evaluate accidental 
radiation exposures because they can be easily identified in Giemsa-stained chromosome 
preparations and pre-exposure background levels are very low. However, the astronaut 
population is unique in that they consent to considerably higher occupational radiation 
exposures than terrestrial radiation workers and, unlike the situation with accident 
victims, pre-exposure levels of chromosome damage can be accurately assessed in 
astronauts, allowing greater sensitivity in biological dose estimations.  
2. Measured Yields of Exchanges in the Peripheral Blood Lymphocytes of 
Astronauts 
The first in vivo studies of chromosome damage in the peripheral blood lymphocytes 
of crew members were conducted in the 1960s during the Gemini program. Bender et al. 
(1967 and 1968) used solid Giemsa staining techniques to assess dicentrics, rings, 
fragments, and chromatid aberrations in blood samples obtained from astronauts who 
participated in the Gemini-III and Gemini-XI missions, which lasted about 5 hours and 3 
days, respectively. No significant increase in damage was detected when samples 
collected before and after flight were compared. More recently, these techniques were 
tested on crew members participating in longer-duration flights on board the Mir space 
station (Testard et al. 1996, Obe et al. 1997, Federenko et al. 2001). Testard et al. (1996) 
studied seven crew members, two of whom participated in flights lasting three weeks or 
less and had no significant increase in chromosome damage post flight, and five of whom 
participated in a six-month mission and had increased chromosome damage post flight. 
Biological dose estimates for the longer-duration flights were calculated using established 
in vitro calibration curves for X-rays and varied among individuals, with values ranging 
from 130 mGy to 455 mGy. Obe et al. (1997) studied crew members who participated in 
space flights lasting from 120 to 198 days, and they reported significant increases in 
chromosome damage post flight for six of the seven individuals studied. Pooled data for 
the six individuals who had increased chromosome damage showed a post flight dicentric 
yield that was roughly 3.5 times that of preflight values. Individual biological doses were 
estimated using published in vitro X-ray-induced dose-response curves, and values 
ranged from 50 mGy to 290 mGy depending on the individual. Limited physical dose 
measurements were reported for the two studies described above, but data indicated that 
the frequencies of aberrations roughly correlated with absorbed radiation dose. A study 
by Federenko et al. (2001) of 22 individuals who participated in space missions lasting an 
average of 4 to 6 months also reported that the mean yields of dicentrics were about 3-
fold greater after flight than before flight. However, large inter-individual variations were 
reported for this group, with some individuals having no appreciable increase in dicentric 
yield post flight. The biological dose estimates for the individual crew members with 
increased dicentric yields varied from 20 to 280 mGy. No comparisons with physical 
dose estimates were given for this study.  
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Evidence from these cytogenetic studies strongly indicates that the radiation dose 
accumulated during a long-duration flight can induce a measurable increase in the yield 
of chromosome damage, whereas the effects of doses encountered during shorter 
missions of a few weeks or less are below the threshold for detection using this technique. 
However, the type of chromosome aberration evaluated is an important factor when 
considering these data. All the studies described above focus on the detection of dicentric 
chromosomes, and it has been well documented that radiation-induced dicentrics in blood 
lymphocytes undergo time-dependent decay. Dicentrics have been estimated to have an 
average half-life of about three years in human peripheral blood lymphocytes, but recent 
studies indicate large variability in decay rate among individuals (Durante et al. 2005). It 
would follow that the use of dicentric aberrations for biodosimetry analysis after missions 
lasting several months or more may not be reliable due to the loss of aberrant cells during 
the mission. In addition, any significant individual variability in the rate of loss of cells 
with dicentrics would indicate that yields could not be accurately corrected for 
elimination of this type of exchange from the blood. 
The introduction of the fluorescence in situ hybridization (FISH) chromosome 
painting technique radically improved the ease and accuracy of assessing yields of 
monocentric aberrations such as translocations (e.g. Lucas 1997). These types of so-
called “stable” chromosome aberrations have a higher probability of survival after cell 
division than unstable aberrations, and are therefore commonly believed to persist in 
peripheral blood cells for many years. This indicates that analysis of translocations would 
be a more appropriate tool than dicentric analysis for assessing the effect of chronic 
radiation exposures such as those encountered during long-duration missions, as well as 
for assessing retrospective radiation doses. Background levels of translocations are higher 
than those of dicentrics; they are known to increase with age and show considerable 
variation between individuals (e.g. Tucker 2001). Although this can be a challenge for 
situations where pre-exposure levels of translocations are not available, such as after 
accidental radiation exposure, it is not a problem for space flight biodosimetry because 
samples can be obtained before flight.  
George et al. (2001a) used chromosome painting to assess the yield of chromosome 
exchanges in the peripheral lymphocytes of six crew members before and after they 
participated in space missions lasting three months or more and in two crew members 
who participated in a 10-day shuttle mission. Post flight increases in chromosome damage 
were detected in all of the crew members on the longer-duration missions, whereas no 
significant change was detected in crew members on the shorter shuttle mission. Doses 
were determined using preflight in vitro dose-response curves for gamma rays that were 
generated using the individual crew members’ blood lymphocytes. Preflight levels of 
translocations were shown to vary considerably between individuals. Doses estimated 
from total chromosome damage ranged from 31 to 166 mGy, depending on the 
individual, and these values roughly correlated with the physical measurements of dose. 
Average relative biological effectiveness (RBE) was estimated by comparing biological 
dose estimates with measured physical doses. Average RBE values were in excellent 
agreement with the average quality factor of 2.5 that was calculated from physical 
readings corrected for the HZE component of the exposure and adjusted to representative 
doses at organ locations. These data confirmed the results of an earlier study by Yang et 
al. (1997) in which FISH chromosome painting was used to assess aberrations in three 
crew members who participated in a space mission lasting 115 days.    
 
3. Biologically Based Risk Estimates 
A direct comparison of risk estimates based on physical dose measurements and 
application of models (NCRP 2000) with estimates based on biological measurements is 
possible because chromosome aberrations in peripheral blood lymphocytes have been 
validated as biomarkers of cancer risk. Risk projections for long-term missions in low 
Earth orbit (LEO) can be obtained from biodosimetry data using the quantitative 
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approach derived from the European Study Group in Cytogenetic Biomarkers and Health 
(ESCH) database, and the proportion of risk attributable to space radiation was found to 
be around 23-24% (Bonassi et al. 2005). The post flight relative increase in aberration 
frequency can then be used directly to estimate the cancer risk, and this biologically based 
estimate can be compared with conventional risk estimates based on physical dosimetry 
and models (NCRP 2000). Through analysis of the cytogenetic data described above, it 
has been determined that the average excess relative risk (ERR) of cancer induction after 
long-term missions in LEO is 0.09, with large inter-individual variations (ranging from 
-0.08 to 0.42) (Durante et al. 2001, Durante 2005). Individual risk estimates in this same 
cohort using conventional assessment leads to an average ERR of 0.05, with a range from 
0.02 to 0.12. Despite the large spread in the “biological” values, it is remarkable that the 
two estimates lie in the same range. In comparison with calculations of equivalent doses 
in the NASA study (George et al. 2001a), these results suggest that current average risk 
estimates for astronauts in LEO are accurate to within a factor of 3 or less (Durante 
2005).  ERR estimates derived from chromosome aberrations present a wider scatter than 
those calculated from doses. Certainly, statistical error involving aberration 
measurements accounts for most of the widened distribution, but inter-individual 
variability in risk may also contribute to this variance. 
4. Cytogenetic Signatures of Space Radiation Exposure  
In addition to detecting simple reciprocal-type chromosome exchanges, chromosome 
painting can be used to detect complex-type exchanges, defined as exchanges involving 
three or more breaks in two or more chromosomes. Many studies have demonstrated that 
after low-linear energy transfer (LET) radiation such as gamma rays and X-rays at 
exposures below 2 Gy, no significant increase in complex exchanges is detected, whereas 
low doses of high-LET radiation, such as the HZE ions in space, are capable of producing 
extremely complex patterns of chromosome damage (George et al. 2003, Durante et al. 
2002). This evidence suggests that complex-type damage can be induced by a single 
particle’s traversal of a cell and indicates that this type of damage can be a biomarker of 
exposure to low doses of high-LET radiation (Anderson et al. 2002). It follows, then, that 
any increase in complex-type chromosome damage detected in blood lymphocytes of 
crew members after space flight would be due entirely to the high-LET component of the 
exposure.   
However, one confounding factor in the assessment of high-LET radiation-induced 
chromosome damage is the influence of delays in progression of the cell cycle from G2 to 
metaphase. Recent ground-based studies have indicated that high-LET-induced 
chromosome damage undergoes a complicated pattern of mitotic delay (George et al. 
2001b), and it is assumed that this is due to the less homogenous nature of this type of 
exposure compared with X-ray or gamma-ray irradiation. When chromosomes in the G2 
phase of the cell cycle are used for the analysis of high-LET-induced cytogenetic damage, 
much higher yields of damage are obtained than with standard metaphase analysis. This is 
due to extensive G2-metaphase cell cycle delays. It is therefore possible that post flight 
expression of complex chromosome damage in crew members’ lymphocytes could be 
influenced by a complicated pattern of mitotic delay after exposure to the mixed radiation 
field encountered in space, and consequently it could be underestimated in metaphase 
samples collected at one time point. To ensure that chromosome damage is not 
underestimated in astronauts’ blood lymphocytes, it may be more appropriate to use the 
chemically induced premature chromosome condensation (PCC) technique, in which 
chromosomes in the G2 phase as well as metaphase are assessed.  
Cytogenetic analysis using FISH painting of chromosomes in lymphocytes from ten 
astronauts after long-term space missions of three months or more revealed that the 
frequency of complex damage was very low and in most cases only one or two complex 
exchanges were detected in several thousand PCC samples analyzed for each individual 
(George et al. 2003). A low background level of complex damage was also detected in 
preflight samples, hampering statistical significance. Similar results were obtained in a 
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cohort of Russian cosmonauts (Durante et al. 2004). In another study, Horstmann et al. 
(2005) used a multiplex FISH technique (MFISH) to assess all chromosomes 
simultaneously in each cell and detected no complex-type exchanges in a total of 3590 
lymphocyte cells pooled from astronauts involved in short- and long-duration space 
missions. However, this study was conducted using standard metaphase analysis and 
therefore does not discount the possibility that complex damage was not expressed due to 
extensive cell-cycle delay. In addition, both Testard et al. (1996) and Obe et al. (1997) 
reported a very low frequency of highly damaged metaphase cells after long-duration 
missions. However, because analysis was conducted using solid staining techniques, these 
studies were limited to so-called “rogue” cells containing multiple dicentric and acentric 
fragments, and again cells were analyzed using standard metaphase techniques. The 
nature of the “rogue” cells is still unclear, but they are generally considered to be 
unrelated to radiation exposure (Mustonen et al. 1998). 
Intrachromosomal exchanges (inversions) have also been suggested as a biomarker of 
exposure to densely ionizing radiation (Hande et al. 2003). Only one group so far 
(Horstmann et al. 2005) has attempted to assess the frequency of intrachromosomal 
exchanges in blood lymphocytes after space flight. For this study, a high-resolution 
multicolor fluorescence banding (mBAND) probe for chromosome 5 was used, and no 
inversions were detected in 2800 cells pooled from 11 astronauts involved in short- and 
long-duration missions.  
5. Persistence of Space Radiation-Induced Cytogenetic Damage   
It has been commonly believed that chromosome translocations would persist in the 
blood lymphocytes for many years. However, as more data become available, evidence 
suggests that this may not always be the case (reviewed in Tucker 2001, IAEA 2001, 
Durante 2005). Some limited data are available on the persistence of chromosome 
aberrations in astronaut peripheral blood lymphocytes. Durante et al. (2003) clearly 
demonstrated that dicentric yields in astronauts decay with time after flight. The authors 
could not measure the complete time dependence of translocations using FISH painting, 
but their results show a lack of correlation between time in space and translocation yields 
(figure 1A.  
No significant correlation was observed between yields of dicentrics or translocations 
and duration of flight or absorbed dose. The yield of aberrations declined rapidly during 
the time interval between flights, and after multiple flights translocation yields were 
similar to background levels before the first mission (figure 1B).  
George et al. (2005) analyzed blood samples collected at various times, beginning 
directly after return from space to more than 5 years after flight. For five of the six 
astronauts studied, the analysis of individual time courses for translocations revealed a 
temporal decline of yields, with half-lives ranging from 10 to 58 months. Since the level 
of stable aberrations depends on the interplay between natural loss of circulating T 
lymphocytes and replenishment from the stem or progenitor cells, the differences in the 
rates of decay could be explained by inter-individual variation in lymphocyte turnover. 
The results indicate possible complications with the use of stable aberrations for 
retrospective dose reconstruction or risk estimates from biological data. It should be 
stressed that space is a unique environment and these results may not be applicable to 
terrestrial radiation exposures. It is possible that confounding factors in the space 
environment, such as stress and microgravity, could induce cell instability. It has been 
shown that space flights induce drastic changes in the immune system, and the ability to 
respond to challenges such as infection is reduced in the space environment.  
The complex time dependence of the yield of chromosome aberrations is apparently a 
severe limitation on the use of cytogenetic endpoints to estimate equivalent dose or risk. 
The result of this biological test will depend strongly on the time after sampling. 
However, it can be argued that the “time factor” does not necessarily reflect a technical 
limitation of the cytogenetic biomarker, but rather provides an individual risk assessment 
rather than the average risk estimate based solely on absorbed dose (Durante et al. 2005). 
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As in the case of individuals who quit smoking at a certain age after years of chronic 
exposure to carcinogens in cigarette smoke, relative risk from radiation decreases with 
time after exposure (as shown in the recent analysis of A-bomb survivors, see Preston et 
al. 2003), and the decrease is likely to show a large inter-individual variability, caused by 
physiological, environmental, and genetic factors. Since these factors are not taken into 
account in biophysical models of radiation action, a reliable picture of the relative risk for 
an individual at a given time after exposure may be derived only by biomarkers of risk. 
6. Methodology Considerations and Suggestions for Standardized Protocols  
After all available data are considered, it appears that cytogenetic biodosimetry can 
be used reliably to reconstruct radiation dose after protracted exposure to space radiation, 
and these data can potentially be used to assess individual health risk. However, it is 
becoming clear that compared with biodosimetry of terrestrial radiation exposure, 
biodosimetry of space radiation exposure has some unique challenges, which must be 
addressed before a standard procedure can be established. It is apparent that several major 
areas should be considered, as addressed below. 
6.1 Collection of Chromosome Samples  
Lymphocytes must be examined in blood samples that were collected before flight to 
establish accurate preflight yields of damage. This not only provides an individual 
baseline for translocations, which are highly variable between individuals, but also 
increases the dose sensitivity of the assay. Considering that chromosome damage may 
undergo a fairly rapid time-dependent decay, post flight samples must be collected within 
a week or two after the mission. Some studies have used samples collected the day after 
return from space. However, it has been noted that the response of lymphocytes to 
phytohemagglutinin (PHA), a chemical that is used to induce lymphocytes to undergo cell 
division, is severely suppressed on the day of return from space. The mitotic index was 
drastically lower in samples collected from three crew members on the day of return from 
a 3-month space mission than it was in preflight samples collected from the same 
individuals (Yang et al. 1997).  The number of cycling cells was much lower, and 
progression through the cell cycle was much slower. This phenomenon, which may be 
related to changes in the immune response and/or other stress and microgravity effects, 
seems to last only a few days. The growth kinetics of PHA-stimulated lymphocytes 
collected 9 days after flight were almost the same as those in preflight samples. Given the 
challenges of collecting chromosome samples within a few days of return from flight, a 
later sampling time (7-14 days after flight) is preferable. 
Samples that have been subjected to chemically induced PCC contain G2-phase as 
well as metaphase cells. Analysis of such samples is preferable to standard metaphase 
analysis. PCC analysis will ensure that any cells undergoing extensive G2-M cell-cycle 
delay will still be included in the analysis. As mentioned above, this method has been 
shown to help avoid population bias after high-LET radiation in vitro and may ensure 
correct yields of complex damage induced in vivo, although this has yet to be proven. In 
addition, PCC samples generally have a higher index of analyzable cells, so that using 
them makes it easier to obtain sufficient cells from samples that are consistently difficult 
to culture. 
6.2 Assessment of Chromosome Damage  
Since it has been well documented that radiation-induced dicentrics undergo fairly 
fast time-dependent decay and will certainly be lost from the blood during a longer 
spaceflight mission, stable monocentric aberrations will provide more accurate 
assessments of dose. A combination of three FISH painting probes for the larger 
chromosome pairs that comprise about 20% of the genome is recommended for analysis. 
This technique allows damage to be scored quickly, and if each chromosome is painted 
with a different color, the detection of complex damage will be maximized while 
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exchanges within the painted chromosomes can also be detected. Data for analysis of 
individual combinations of chromosomes can be extrapolated to whole-genome 
equivalent values using the appropriate calculations (for example, see George et al. 
2001a). Use of MFISH techniques is not recommended for routine biodosimetry analysis 
because analysis of individual cells takes a considerable amount of time.    
The analysis of complex-type exchanges could provide valuable information about 
the high-LET component of radiation exposure, as any significant increase will likely be 
due to heavy ions. However, it appears this type of exchange is quite rare and it is 
unlikely that valuable data can be obtained using the average number of cells analyzed for 
these tests.  
One other important consideration when scoring chromosome damage for dose 
estimations is that clonal exchanges must be identified and excluded. Several recent 
studies have indicated that some individuals’ blood lymphocytes possess cells with 
balanced chromosome abnormalities that have clonally expanded in vivo, resulting in a 
population of cells with identical rearrangements. Including these clonal exchanges can 
result in an overestimation of radiation-induced damage and therefore influence the 
accuracy of dose calculations. Clonal exchanges may be more prevalent than previously 
thought. In fact, in one study clonal aberrations were identified in three of twelve 
astronauts (George et al 2004). These clonal cells were present in samples collected both 
before and after space flight, and yields were higher than those previously reported for 
healthy individuals in this age range (40-52 years of age). The individuals with clonal 
aberrations were followed over several months, and the yields of all clones decreased 
during this period. It is possible that the inclusion of clonal exchanges could explain some 
of the inter-individual biological differences in dose estimates for astronauts. Since clonal 
aberrations may be associated with increased risk of tumorigenesis, it is important for risk 
assessment as well as biodosimetry to accurately identify cells containing clonal 
rearrangements. 
6.3 Dose Limitations    
The radiation dose incurred during shorter space flight missions does not produce 
effects detectable by currently available cytogenetic biodosimetry techniques. The lowest 
dose that can be assessed seems to be around 10 cGy. This generally restricts the use of 
biodosimetry to missions lasting at least 3 months. Using the FISH technique, several 
thousand cells should be analyzed in both pre- and post flight samples to obtain 
statistically significant data, although exact numbers can vary depending on the 
individual’s background frequencies of damage.  
6.4 Individual Sensitivity  
Recent data indicate that in vitro dose response for chromosome damage may vary 
for some individuals (figure 2). If this is the case, then one standard calibration curve can 
not be used for all individuals and it is necessary to generate a preflight in vitro 
calibration curve for blood lymphocytes from each crew member before their 
participation in the mission. This will indicate if the particular individual has a greater 
predisposition for sensitivity to radiation and should be monitored more closely. In 
addition, if the same combination of chromosomes is assessed before and after flight and 
individual dose-response curves are used, then the results can be compared directly 
without the need for subtracting background yield of chromosome damage. This results in 
substantially decreased error in dose estimations.  
Recent estimates have put the overall percentage of individuals heterozygous for the 
ataxia telangiectasia (A-T) gene at around 3% of the human population. These individuals 
have defective DNA repair capabilities that make them more sensitive to radiation, and 
they are clearly at greater risk of health effects due to radiation exposure. If these 
percentages are correct, it is very likely that the astronaut population includes some A-T 
heterozygous individuals. Clearly the issue of individual sensitivity to space radiation is 
very important and data are limited. More study is required in this area. 
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6.5 Dose Estimations  
As mentioned above, if the same combination of chromosomes is assessed for each 
sample, then post flight increases can be obtained by subtracting preflight background 
yields from the post flight yield, and biologically determined dose can be calculated 
directly using the curve fit for the preflight calibration curve. At least two doses below 10 
cGy should be used for the in vitro calibration to increase the accuracy of the curve-fitting 
for doses within the range encountered during space flight. At least five different doses 
are required for the calibration curve, and using the probes that comprise 20% of the 
whole genome, several thousand cells must be analyzed to generate sufficient data for 
curve-fitting. 
6.6 Influence of Multiple Flights  
The recent study of crew members after multiple flights (Durante et al. 2003) 
indicates that individuals who have been involved in several missions may have an 
adaptive response to space radiation exposure. Given that these individuals may have less 
of an increase in chromosome damage than would be expected after multiple flights, it 
may not be possible to accurately assess their dose using these methods. It is important, 
therefore, to research an individual’s previous radiation exposure from earlier space 
flights and possibly medical procedures, and to take this into consideration when 
evaluating biodosimetry data. This study of adaptive response is very interesting and it is 
important that the phenomenon be investigated further. 
 
References 
 
Anderson, R.M., Stevens, D.L., Goodhead, D.T. M-FISH analysis shows that complex 
chromosome aberrations induced by alpha -particle tracks are cumulative products of 
localized rearrangements. Proc. Natl. Acad. Sci. USA 99, 12167-12172, 2002. 
 
Bender, M.A., Gooch, P.C., Kondo, S. The Gemini-3 S-4 spaceflight-radiation interaction 
experiment. Radiat. Res. 31, 91-111, 1967. 
 
Bender, M.A, Gooch, P.C., Kondo, S. The Gemini XI S-4 spaceflight-radiation 
interaction experiment: the human blood experiment. Radiat. Res. 34, 228-238, 1968. 
 
Bonassi, S., Ugolini, D., Kirsh-Volders, M., Stromberg, U., Vermeulen, R., Tucker, J.D. 
Human population studies with cytogenetic biomarkers: review of the literature and 
future prospectives. Environ. Mol. Mutagen 45, 258-270, 2005. 
 
Cucinotta, F.A., Durante, M. Cancer risk from exposure to galactic cosmic rays: 
implications for space exploration by human beings. Lancet Oncol.  7, 431-435, 2006. 
 
Durante, M. Biomarkers of space radiation risk. Radiat. Res. 164, 467-473, 2005. 
 
Durante, M., Bonassi, S., George, K., Cucinotta, F.A. Risk estimation based on 
chromosomal aberrations induced by radiation. Radiat. Res. 156, 662-667, 2001. 
 
Durante, M., George, K., Wu, H., Cucinotta, F.A. Karyotypes of human lymphocytes 
exposed to high-energy iron ions. Radiat. Res. 158, 581-590, 2002. 
 
Durante, M., Snigiryova, G., Akaeva, E., Bogomazova, S., Druzhinin, S., Federenko, B., 
Greco, O., Novitskaya, N., Rubanovich, A., Shevchenko, V., von Recklinghausen, U., 
8 
Obe, G. Chromosome aberration dosimetry in cosmonauts after single or multiple flights. 
Cytogenet. Genome Res. 103, 40-46, 2003. 
Durante, M., Ando, K., Furusawa, Y., Obe, G., George, K., Cucinotta, F.A. Complex 
chromosomal rearrangements induced in vivo by heavy ions. Cytogenet. Genome Res. 
104, 240-244, 2004. 
 
Federenko, B., Druzhinin, S., Yudaeva, L., Petrov, V., Akatov, Y., Snigiryova, G., 
Novitskaya, N., Shevchenko, V., Rubanovich, A. Cytogenetic studies of blood 
lymphocytes from cosmonauts after long-term space flights on Mir station. Adv. Space 
Res. 27, 355-359, 2003. 
 
George, K., Durante, M., Wu, H., Willingham, V., Badhwar, G., Cucinotta, F.A. 
Chromosome aberrations in astronauts’ blood lymphocytes after space flight. Radiat. Res. 
156, 731-738, 2001a. 
 
George, K., Wu, H., Willingham, V., Furusawa, Y., Kawata, T., Cucinotta, F.A. High- 
and low-LET induced chromsome damage in human lymphocytes: a time course of 
aberrations in metaphase and interphase. Int. J. Radiat. Biol. 77, 175-183, 2001b. 
 
George, K., Wu, H., Willingham, V., Cucinotta, F.A. The effect of space radiation on the 
induction of chromosome damage. Physica. Medica, 17, 224-228, 2001c. 
 
George, K., Durante, M., Willingham, V., Wu, H., Yang, T.C., Cucinotta, F.A. Biological 
effectiveness of accelerated particles for the induction of chomosome damage measured 
in metaphase and interphase human lymphoyctes. Radiat. Res. 160, 425-435, 2003a. 
 
George, K., Durante, M., Wu, H., Willingham, V., Cucinotta, F.A. In vivo and in vitro 
measurements of complex-type chromosomal exchanges induced by heavy ions. Adv. 
Space Res. 31, 1525-1535, 2003b. 
 
George, K., Durante, M., Willingham, V., Cucinotta, F.A. Chromosome aberrations of 
clonal origin are present in astronauts' blood lymphocytes. Cytogenet. Genome Res. 104, 
245-251, 2004. 
 
George, K., Willingham, V., Cucinotta, F.A. Stability of chromosome aberrations in the 
blood lymphocytes of astronauts after space flight by FISH chromosome painting. Radiat. 
Res. 164, 474-480, 2005. 
 
Hortsmann, M., Durante, M., Johannes, C., Pieper, R., Obe, G. Space radiation does not 
induce a significant increase of intrachromosomal exchanges in astronauts’ lymphocytes. 
Radiation Environ. Biophysics 44, 219-224, 2005. 
 
IAEA Cytogenetic Analysis for radiation dose assessment. Technical Report No. 405. 
International Atomic Energy Agency, Vienna, 2001. 
 
Lucas, J.N. Dose reconstruction for individuals exposed to ionizing radiation using 
chromosome painting. Radiat. Res. 148, 33-38, 1997. 
 
Mustonen, R., Lindholm, C., Tawn, E.J., Sabatier, L., Salomaa, S. The incidence of 
cytogenetically abnormal rogue cells in peripheral blood. Int. J. Radiat. Biol. 74, 781-785, 
1998. 
 
NCRP Radiation Protection Guidance for Activities in Low-Earth Orbit. NCRP Report 
No. 132, Bethesda, Maryland, 2000. 
 
9 
NCRP Operational Radiation Safety Program for Astronauts in Low-Earth Orbit: a Basic 
Framework. NCRP Report No. 142, Bethesda, Maryland, 2002. 
 
Obe, G., Johannes, I., Johannes, C., Hallman, K., Reitz, G., Facius, R. Chromosomal 
aberrations in blood lymphocytes of astronauts after long-term space flights. Int. J. 
Radiat. Biol. 72, 727-734, 1997. 
 
Preston, D.L., Pierce, D.A., Shimizu, Y., Ron, E., Mabuchi, K. Dose response and 
temporal patterns of radiation-associated solid cancer risks. Health Phys. 85, 43-46, 2003. 
 
Testard, L., Ricoul, M., Hoffschir, F., Flury-Herard, A., Dutrillaux, B., Federenko, B., 
Gerasimenko, V., Sabatier, L. Radiation-induced chromosome damage in astronauts’ 
lymphocytes. Int. J. Radiat. Biol. 70, 403-411, 1996. 
 
Tucker, J.D. FISH cytogenetics and the future of radiation biodosimetry. Radiat. Prot. 
Dosimetry 97, 55-60, 2001. 
 
Yang, T.C., George, K., Johnson, A.S., Durante, M., Fedorenko, B.S. Biodosimetry 
results from space flight Mir-18. Radiat. Res. 48, 17-23, 1997. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure Captions 
 
 
Figure 1. Time course of chromosome aberration in a study on 22 Russian cosmonauts. 
A. Relationship between translocation frequency (WGE) and total duration of space 
sojourns for cosmonauts involved in multiple space flights. Each symbol represents a 
different cosmonaut. B. Kinetics of dicentrics in one cosmonaut involved in 4 
spaceflights.  The dicentric frequency (per 1000 lymphocytes) is plotted vs. the time from 
the first blood draw used for the cytogenetic test. Vertical bars indicate the times of 
launch and landing for the mission, and the number between the bars indicates the flight 
number for the cosmonaut.  The line connecting the datapoints is a guide for the eye. 
Plots from reference Durante et al. (2003), reproduced with permission of Karger 
Publishers, Basel. 
 
Figure 2. Dose-response curves for chromosome damage induced after in vitro irradiation 
with gamma rays. Each symbol represents a different crew member. Bars represent 
standard error.  
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